S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
Log in
NYSEARCA:BOUT

Innovator IBD Breakout Opportunities ETF Stock Forecast, Price & News

$23.50
-0.58 (-2.41 %)
(As of 10/30/2020 12:00 AM ET)
Add
Today's Range
$23.43
Now: $23.50
$24.03
50-Day Range
$22.06
MA: $23.85
$25.56
52-Week Range
$15.05
Now: $23.50
$25.70
Volume3,337 shs
Average Volume3,612 shs
Market Capitalization$5.87 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Geographic Exposure of BOUT

Currency Exposure of BOUT

Sector Exposure of BOUT

Industry Exposure of BOUT

Basic Details

Issuer Innovator Capital Management
Fund NameInnovator IBD Breakout Opportunities ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:BOUT
Inception Date9/13/2018
Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkIBD Breakout Stocks Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$6.16 million
Average Daily Volume$2,551.20
Discount/Premium-0.11%

ETF Expenses

Management Fee0.80%
Other Expenses0.00%
Total Expenses0.80%
Fee Waiver0.00%
Net Expenses0.80%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorInnovator Capital Management, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market Maker
$23.50
-0.58 (-2.41 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BOUT News and Ratings via Email

Sign-up to receive the latest news and ratings for BOUT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Frequently Asked Questions

How has Innovator IBD Breakout Opportunities ETF's stock been impacted by COVID-19?

Innovator IBD Breakout Opportunities ETF's stock was trading at $17.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BOUT shares have increased by 31.2% and is now trading at $23.4959.
View which stocks have been most impacted by COVID-19
.

What is Innovator IBD Breakout Opportunities ETF's stock symbol?

Innovator IBD Breakout Opportunities ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BOUT."

Who are Innovator IBD Breakout Opportunities ETF's major shareholders?

Innovator IBD Breakout Opportunities ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (5.30%).

Which institutional investors are selling Innovator IBD Breakout Opportunities ETF stock?

BOUT stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc..

How do I buy shares of Innovator IBD Breakout Opportunities ETF?

Shares of BOUT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Innovator IBD Breakout Opportunities ETF's stock price today?

One share of BOUT stock can currently be purchased for approximately $23.50.

How big of a company is Innovator IBD Breakout Opportunities ETF?

Innovator IBD Breakout Opportunities ETF has a market capitalization of $5.87 million.

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.